Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors

By Mulloy L.L.   Wright F.   Hall M.L.   Moore M.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1210-1213

Elsevier

Access to resources Recommend Favorite

Chronic rejection of cadaveric renal allografts: role of acute rejection episodes

By Khauli R.B.   Fan P.-Y.   Lovewell T.D.   Blute R.D.   Ayvazian P.   Pullman J.M.   Valliere S.A.   Stoff J.S.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1306-1307

Elsevier

Access to resources Recommend Favorite

Reduction in the Incidence of Early Rejection in Cadaveric Renal Allograft Recipients Treated with ATGAM Induction and Sequential Mycophenolate Mofetil

By Florence L.S.   Howard D.R.   Chapman P.H.   Lieberman J.   Perkinson D.T.   Marks W.H.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 313-314

Elsevier

Access to resources Recommend Favorite

A retrospective analysis of a sirolimus/prograf regimen for the prevention of acute rejection in recipients of primary mismatched renal allografts

By Youseff N.   Small S.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1653-1655

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil, ATG, and cyclosporine in the induction treatment of renal transplant recipients minimizes the incidence of acute rejection episodes

By Puig J.M.   Lloveras J.   Fernandez-Crespo P.   Mir M.   Marcas L.I.   Manresa J.M.   Masramon J.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2226-2227

Elsevier

Access to resources Recommend Favorite